Aredia

Aredia is a brand name of pamidronate, approved by the FDA in the following formulation(s):

AREDIA (pamidronate disodium - injectable; injection)

• 
  Manufacturer: NOVARTIS
  
  Approval date: October 31, 1991
  
  Strength(s): 30MG/VIAL ^[RLD][AP]

Has a generic version of Aredia been approved?

Yes. The following products are equivalent to Aredia:

pamidronate disodium injectable; injection

• 
  Manufacturer: APP PHARMS
  
  Approval date: May 6, 2002
  
  Strength(s): 30MG/VIAL ^[AP]


• 
  Manufacturer: AREVA PHARMS
  
  Approval date: November 26, 2008
  
  Strength(s): 30MG/VIAL ^[AP]


• 
  Manufacturer: BEDFORD
  
  Approval date: April 30, 2001
  
  Strength(s): 30MG/VIAL ^[AP]


• 
  Manufacturer: MN PHARMS
  
  Approval date: March 10, 2009
  
  Strength(s): 30MG/VIAL ^[AP]


• 
  Manufacturer: SUN PHARMA GLOBAL
  
  Approval date: December 24, 2008
  
  Strength(s): 30MG/VIAL ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Aredia. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Aredia.

See also...

• Aredia Consumer Information (Wolters Kluwer)
• Aredia Consumer Information (Cerner Multum)
• Aredia Advanced Consumer Information (Micromedex)
• Aredia AHFS DI Monographs (ASHP)
• Pamidronate Consumer Information (Wolters Kluwer)
• Pamidronate Consumer Information (Cerner Multum)
• Pamidronate Intravenous Advanced Consumer Information (Micromedex)
• Pamidronate Disodium AHFS DI Monographs (ASHP)